Scientists hunt clues to why lung cancer comes back after treatment
NCT ID NCT07363252
Summary
This study aims to understand why lung cancer returns in patients who had surgery and took the drug osimertinib afterward. Researchers will analyze tissue and blood samples from 100 patients whose cancer came back during or after treatment. The goal is to identify genetic changes that might explain why the cancer recurred, which could help guide future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EGFR-MUTATED NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
"OSPEDALE P. PEDERZOLI" Casa di Cura Privata S.p.A.
Peschiera del Garda, VR, 37019, Italy
-
A.O.U. "Maggiore della Carita'"- S.C.D.U Oncologia
Novara, 28100, Italy
-
A.S.S.T - Monza Ospedale San Gerardo
Monza, MB, 20900, Italy
-
AOU Integrata di Verona - Ospedale Borgo Trento
Verona, VR, 37126, Italy
-
AOU San Luigi Gonzaga - SSD oncologia polmonare
Orbassano, TO, 10043, Italy
-
Asst Papa Giovanni Xxiii Sc Oncologia
Bergamo, BG, 24127, Italy
-
Dip Oncologia-Ematologia - UO Oncologia AOU Policlinico di Modena
Modena, MO, 41124, Italy
-
European Institute of Oncology IRCCS
Milan, MI, 20141, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, MI, 20113, Italy
-
Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS
Roma, RM, 00168, Italy
-
Fondazione Policlinico Universitario Campus Bio-Medico
Roma, RM, 00128, Italy
-
Grande Ospedale Metropolitano Niguarda Ca' Granda
Milan, MI, 20162, Italy
-
Humanitas Istituto Clinico Catanese Contrada Cubba
Misterbianco, CT, 95045, Italy
-
IRCCS Oncologico Giovanni Paolo II
Bari, BA, 70124, Italy
-
Ifo-Istituto Regina Elena - Oncologia Medica 1
Roma, RM, 00144, Italy
-
Irccs Humanitas Research Hospital
Milan, MI, 20089, Italy
-
Oncologia Clinica Sperimentale Toraco-Polmonare, IRCCS Pascale di Napoli
Napoli, 80131, Italy
-
Ospedale San Raffaele Dipartimento di Oncologia Medica
Milan, MI, 20132, Italy
-
S.C. Oncologia Provinciale, Azienda USL-IRCCS di Reggio Emilia
Reggio Emilia, RE, 42123, Italy
-
S.O.C. di Oncologia Medica e dei Tumori Immuno-correlati, Centro di Riferimento Oncologico IRCCS
Aviano, PN, 33081, Italy
-
SC Oncologia ASST Sette Laghi "Ospedale di Circolo e Fondazione Macchi "
Varese, VA, 21100, Italy
-
U.O.C. Oncologia Medica Azienda Unità Sanitaria Locale della Romagna
Ravenna, RA, 48100, Italy
-
UOC di Oncologia Medica 2 - IOV Istituto Oncologico Veneto
Padua, PD, 35128, Italy
-
UOC di Oncologia Medica Azienda Ospedaliero-Universitaria di Parma
Parma, PR, 43126, Italy
-
UOC di Oncologia Medica IRCCS - Policlinico S. Orsola Malpighi
Bologna, BO, 40138, Italy
Conditions
Explore the condition pages connected to this study.